La greffe de cornée est-elle une option de traitement ?
Oui, la greffe de cornée peut être nécessaire en cas de défaillance sévère.
Greffe de cornéeDéfaillance cornéenne
#3
Les gouttes oculaires peuvent-elles aider ?
Oui, des gouttes oculaires peuvent réduire l'inflammation et améliorer le confort.
Gouttes oculairesInflammation
#4
Y a-t-il des traitements non chirurgicaux disponibles ?
Oui, des traitements médicaux et des thérapies de soutien sont disponibles.
Thérapies médicalesSoutien thérapeutique
#5
Les traitements varient-ils selon la gravité de la condition ?
Oui, les traitements sont adaptés en fonction de la gravité et des symptômes.
Gravité de la conditionAdaptation des traitements
Complications
5
#1
Quelles complications peuvent survenir avec des problèmes de Descemet ?
Les complications incluent l'œdème cornéen, la perte de vision et l'infection.
Œdème cornéenPerte de vision
#2
L'infection est-elle une complication possible ?
Oui, une infection peut survenir, surtout après une chirurgie ou un traumatisme.
Infection oculaireChirurgie cornéenne
#3
Les cicatrices cornéennes peuvent-elles résulter de problèmes de Descemet ?
Oui, des cicatrices peuvent se former, affectant la clarté de la vision.
Cicatrices cornéennesClarté de la vision
#4
Peut-on développer un glaucome à cause de problèmes de Descemet ?
Oui, des problèmes de Descemet peuvent augmenter le risque de glaucome.
GlaucomeRisque accru
#5
Les complications peuvent-elles nécessiter une intervention chirurgicale ?
Oui, certaines complications graves peuvent nécessiter une intervention chirurgicale.
Intervention chirurgicaleComplications graves
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour les problèmes de Descemet ?
Les antécédents familiaux, les traumatismes oculaires et certaines maladies augmentent le risque.
Antécédents familiauxTraumatismes oculaires
#2
L'âge est-il un facteur de risque ?
Oui, le vieillissement peut augmenter le risque de défaillance de la membrane de Descemet.
VieillissementRisque accru
#3
Les maladies systémiques influencent-elles la santé de Descemet ?
Oui, des maladies comme le diabète peuvent affecter la santé cornéenne.
DiabèteSanté cornéenne
#4
Le port de lentilles de contact est-il un facteur de risque ?
Oui, un usage inapproprié des lentilles peut augmenter le risque d'infections.
Lentilles de contactInfections oculaires
#5
Les allergies peuvent-elles être un facteur de risque ?
Oui, les allergies oculaires peuvent contribuer à l'inflammation et aux problèmes de Descemet.
Allergies oculairesInflammation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lame limitante postérieure : Questions médicales les plus fréquentes",
"headline": "Lame limitante postérieure : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lame limitante postérieure : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-30",
"dateModified": "2025-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lame limitante postérieure"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Membrane basale",
"url": "https://questionsmedicales.fr/mesh/D001485",
"about": {
"@type": "MedicalCondition",
"name": "Membrane basale",
"code": {
"@type": "MedicalCode",
"code": "D001485",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A10.615.179"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lame limitante postérieure",
"alternateName": "Descemet Membrane",
"code": {
"@type": "MedicalCode",
"code": "D003886",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Steven E Wilson",
"url": "https://questionsmedicales.fr/author/Steven%20E%20Wilson",
"affiliation": {
"@type": "Organization",
"name": "Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: wilsons4@ccf.org."
}
},
{
"@type": "Person",
"name": "Takahiko Hayashi",
"url": "https://questionsmedicales.fr/author/Takahiko%20Hayashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Nihon University of Medicine, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Nir Sorkin",
"url": "https://questionsmedicales.fr/author/Nir%20Sorkin",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada."
}
},
{
"@type": "Person",
"name": "Clara C Chan",
"url": "https://questionsmedicales.fr/author/Clara%20C%20Chan",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada."
}
},
{
"@type": "Person",
"name": "David S Rootman",
"url": "https://questionsmedicales.fr/author/David%20S%20Rootman",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.",
"datePublished": "2023-01-18",
"url": "https://questionsmedicales.fr/article/36652189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13187-023-02264-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate-Specific Antigen Screening in Transgender Patients.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36344317",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.eururo.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35860909",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pros.24414"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer].",
"datePublished": "2023-09-13",
"url": "https://questionsmedicales.fr/article/37702749",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02189-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tissus",
"item": "https://questionsmedicales.fr/mesh/D014024"
},
{
"@type": "ListItem",
"position": 3,
"name": "Membranes",
"item": "https://questionsmedicales.fr/mesh/D008566"
},
{
"@type": "ListItem",
"position": 4,
"name": "Membrane basale",
"item": "https://questionsmedicales.fr/mesh/D001485"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lame limitante postérieure",
"item": "https://questionsmedicales.fr/mesh/D003886"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lame limitante postérieure - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lame limitante postérieure",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lame limitante postérieure",
"description": "Comment diagnostiquer une pathologie de la membrane de Descemet ?\nQuels tests sont utilisés pour évaluer la membrane de Descemet ?\nQuels signes indiquent une défaillance de la membrane de Descemet ?\nLa biopsie est-elle nécessaire pour diagnostiquer des anomalies ?\nQuels symptômes peuvent indiquer un problème avec la membrane de Descemet ?",
"url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Prostate-Specific+Antigen#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lame limitante postérieure",
"description": "Quels sont les symptômes d'une défaillance de la membrane de Descemet ?\nLa rougeur de l'œil est-elle un symptôme associé ?\nPeut-on ressentir des démangeaisons avec des problèmes de Descemet ?\nLes troubles visuels sont-ils fréquents avec des anomalies de Descemet ?\nLa douleur oculaire est-elle un symptôme courant ?",
"url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Prostate-Specific+Antigen#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lame limitante postérieure",
"description": "Comment prévenir les problèmes de la membrane de Descemet ?\nLes examens réguliers des yeux sont-ils importants ?\nUne bonne hygiène oculaire peut-elle prévenir des problèmes ?\nLes allergies oculaires peuvent-elles affecter la membrane de Descemet ?\nLe port de lentilles de contact nécessite-t-il des précautions ?",
"url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Prostate-Specific+Antigen#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lame limitante postérieure",
"description": "Quels traitements sont disponibles pour les problèmes de Descemet ?\nLa greffe de cornée est-elle une option de traitement ?\nLes gouttes oculaires peuvent-elles aider ?\nY a-t-il des traitements non chirurgicaux disponibles ?\nLes traitements varient-ils selon la gravité de la condition ?",
"url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Prostate-Specific+Antigen#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lame limitante postérieure",
"description": "Quelles complications peuvent survenir avec des problèmes de Descemet ?\nL'infection est-elle une complication possible ?\nLes cicatrices cornéennes peuvent-elles résulter de problèmes de Descemet ?\nPeut-on développer un glaucome à cause de problèmes de Descemet ?\nLes complications peuvent-elles nécessiter une intervention chirurgicale ?",
"url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Prostate-Specific+Antigen#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lame limitante postérieure",
"description": "Quels sont les facteurs de risque pour les problèmes de Descemet ?\nL'âge est-il un facteur de risque ?\nLes maladies systémiques influencent-elles la santé de Descemet ?\nLe port de lentilles de contact est-il un facteur de risque ?\nLes allergies peuvent-elles être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Prostate-Specific+Antigen#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une pathologie de la membrane de Descemet ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen ophtalmologique complet, incluant la tomographie et la microscopie, est essentiel."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la membrane de Descemet ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pachymétrie et l'optique cohérente par tomographie sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une défaillance de la membrane de Descemet ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un œdème cornéen et une opacité cornéenne peuvent signaler une défaillance."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle nécessaire pour diagnostiquer des anomalies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie n'est généralement pas nécessaire, les examens non invasifs suffisent."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec la membrane de Descemet ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vision floue, douleur oculaire et rougeur peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une défaillance de la membrane de Descemet ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent vision floue, douleur, et sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "La rougeur de l'œil est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rougeur de l'œil peut être un symptôme d'inflammation ou d'irritation."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des démangeaisons avec des problèmes de Descemet ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des démangeaisons peuvent survenir en raison d'irritation ou d'allergies."
}
},
{
"@type": "Question",
"name": "Les troubles visuels sont-ils fréquents avec des anomalies de Descemet ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles visuels sont fréquents et peuvent varier en gravité."
}
},
{
"@type": "Question",
"name": "La douleur oculaire est-elle un symptôme courant ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur oculaire est un symptôme courant associé aux problèmes de Descemet."
}
},
{
"@type": "Question",
"name": "Comment prévenir les problèmes de la membrane de Descemet ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les traumatismes oculaires et porter des lunettes de protection peut aider."
}
},
{
"@type": "Question",
"name": "Les examens réguliers des yeux sont-ils importants ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers permettent de détecter précocement les problèmes."
}
},
{
"@type": "Question",
"name": "Une bonne hygiène oculaire peut-elle prévenir des problèmes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir une bonne hygiène oculaire aide à prévenir les infections et irritations."
}
},
{
"@type": "Question",
"name": "Les allergies oculaires peuvent-elles affecter la membrane de Descemet ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les allergies peuvent provoquer des inflammations affectant la membrane."
}
},
{
"@type": "Question",
"name": "Le port de lentilles de contact nécessite-t-il des précautions ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est crucial de suivre les recommandations pour éviter les complications."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les problèmes de Descemet ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments anti-inflammatoires et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "La greffe de cornée est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la greffe de cornée peut être nécessaire en cas de défaillance sévère."
}
},
{
"@type": "Question",
"name": "Les gouttes oculaires peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des gouttes oculaires peuvent réduire l'inflammation et améliorer le confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non chirurgicaux disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements médicaux et des thérapies de soutien sont disponibles."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la gravité de la condition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés en fonction de la gravité et des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des problèmes de Descemet ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'œdème cornéen, la perte de vision et l'infection."
}
},
{
"@type": "Question",
"name": "L'infection est-elle une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection peut survenir, surtout après une chirurgie ou un traumatisme."
}
},
{
"@type": "Question",
"name": "Les cicatrices cornéennes peuvent-elles résulter de problèmes de Descemet ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cicatrices peuvent se former, affectant la clarté de la vision."
}
},
{
"@type": "Question",
"name": "Peut-on développer un glaucome à cause de problèmes de Descemet ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de Descemet peuvent augmenter le risque de glaucome."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles nécessiter une intervention chirurgicale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications graves peuvent nécessiter une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les problèmes de Descemet ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes oculaires et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut augmenter le risque de défaillance de la membrane de Descemet."
}
},
{
"@type": "Question",
"name": "Les maladies systémiques influencent-elles la santé de Descemet ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent affecter la santé cornéenne."
}
},
{
"@type": "Question",
"name": "Le port de lentilles de contact est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un usage inapproprié des lentilles peut augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les allergies peuvent-elles être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les allergies oculaires peuvent contribuer à l'inflammation et aux problèmes de Descemet."
}
}
]
}
]
}
Department of Ophthalmology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. Electronic address: namrata.sharma@gmail.com.
There is controversy on prostate cancer screening with the prostate-specific antigen (PSA) test in the USA, and as a result, there has been an increased push for physicians to have a thorough discussi...
Approximately 0.4-1.3% of the worldwide population is transgender. Although the exact prevalence is unknown, there is an increase in open identification as transgender. Among transgender women (TW), t...
To assess our current understanding of CaP incidence and prostate-specific antigen (PSA) screening in TW....
We performed a nonsystematic narrative review of all PubMed publications through June 2022 according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement. Given ...
There is no consensus regarding PSA screening in TW from any of the major societies, and TW are largely absent from guidelines. Case report data suggest that TW with CaP may have more aggressive disea...
We are in the infancy of our understanding of PSA screening in TW. Important avenues for future research include understanding the risks/benefits of PSA screening in TW, how best to mitigate potential...
We examined patterns of prostate cancer screening for transgender women. Little is known about prostate cancer incidence or screening in this population. Additional research is needed to establish gui...
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly incorporated in the therapeutic algorithm of patients with metastatic castration-resistant prostate cancer ...
In this bicentric analysis, we included 184 mCRPC patients treated with...
A total of 114/184 patients (62.0%) showed any PSA decline (PSA response >50%, 55/184 [29.9%]). For individuals exhibiting a PSA decline >50%, OS of 19 months was significantly longer relative to nonr...
In mCRPC patients scheduled for RLT, early biochemical response was tightly linked to prolonged survival, irrespective of the magnitude of PSA decline. As such, even in patients with PSA decrease of l...
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Prostate-specific antigen (PSA) screening for prostate cancer is controversial but may be associated with benefit for certain high-risk groups....
To evaluate associations of county-level PSA screening prevalence with prostate cancer outcomes, as well as variation by sociodemographic and clinical factors....
This cohort study used data from cancer registries based in 8 US states on Hispanic, non-Hispanic Black, and non-Hispanic White men aged 40 to 99 years who received a diagnosis of prostate cancer betw...
County-level PSA screening prevalence was estimated using the Behavior Risk Factor Surveillance System survey data from 2004, 2006, 2008, 2010, and 2012 and weighted by population characteristics....
Multivariable logistic, Cox proportional hazards regression, and competing risks models were fit to estimate adjusted odds ratios (AOR) and adjusted hazard ratios (AHR) for associations of county-leve...
Of 814 987 men with prostate cancer, the mean (SD) age was 67.3 (9.8) years, 7.8% were Hispanic, 12.2% were non-Hispanic Black, and 80.0% were non-Hispanic White; 17.0% had advanced disease. There wer...
This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of PSA screening was associated with lower odds of advanced disease, all-cause mortality, an...
The incidence rate of prostate cancer (PCa) has continued to rise in Korea. This study aimed to construct and evaluate a 5-year PCa risk prediction model using a cohort with PSA < 10 ng/mL by incorpor...
The PCa risk prediction model including PSA levels and individual risk factors was constructed using a cohort of 69,319 participants from the Kangbuk Samsung Health Study. 201 registered PCa incidence...
The risk prediction model included age, smoking status, alcohol consumption, family history of PCa, past medical history of dyslipidemia, cholesterol levels, and PSA level. Especially, an elevated PSA...
Our risk prediction model was effective in predicting PCa in a population according to PSA levels. When PSA levels are inconclusive, an assessment of both PSA and specific individual risk factors (e.g...
For metastatic hormone naïve prostate cancer patients, androgen deprivation therapy (ADT) with escalation therapy including docetaxel and/or androgen targeting drugs is the standard therapy. However, ...
Prostate biopsies from 92 patients with metastatic hormone naïve PC (PSA > 80 ng/mL or clinical metastases) were immunohistochemically evaluated for PSA and Ki67. Gene expression analysis was performe...
The immunohistochemical score for PSA was the strongest prognostic factor for progression-free and overall survival after ADT. Consequently, the ratio between Ki67 and PSA displayed a stronger prognos...
PSA and Ki67 immunoreactive scores are prognostic in the metastatic hormone-sensitive setting, with PSA being superior. The combination of Ki67 and PSA did not give additional prognostic value. The re...
To investigate the value of serum free prostate-specific antigen density (fPSAD) in the diagnosis of prostate cancer (PCa)....
The data of 558 patients who underwent transrectal ultrasound-guided prostate biopsy were retrospectively analyzed. According to the pathological results, the patients were divided into a PCa group an...
tPSA, PSAD, (f/t)/PSAD, and fPSAD had high accuracy in predicting PCa with AUC values of 0.820, 0.900, 0.846, and 0.867. fPSAD showed lower diagnostic sensitivity but significantly higher specificity ...
With the optimal cutoff value of 0.062, fPSAD has a higher diagnostic value for PCa than tPSA, f/tPSA, (f/t)/PSAD, and PSAD, and can well predict the risk of PCa, significantly improve the clinical di...
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
